#United States #Ultrasound #Fishers #Esaote #Schiller Americas

Esaote and Schiller Americas Unite for a Groundbreaking Partnership

In a significant move for the medical imaging landscape, Esaote, renowned for its pioneering medical imaging technologies, has announced a strategic collaboration with Schiller Americas, a key player in cardiopulmonary diagnostics. This partnership, unveiled on November 13, 2025, is set to greatly amplify the availability of advanced ultrasound solutions in the cardiology sector throughout the United States.

Enhancing the Cardiology Imaging Market

The collaboration marks a pivotal development in the ongoing efforts to bolster cardiovascular care in the U.S. By integrating Esaote's state-of-the-art ultrasound systems, such as the MyLab™ E80, MyLab™ A70, and MyLab™ Omega eXP, into Schiller Americas' extensive network, the two companies aim to deliver comprehensive diagnostic tools directly to healthcare providers. This strategic partnership not only enhances sales channels but also reinforces both companies' commitment to improving patient outcomes through superior cardiac care.

Thomas Will, Director of Ultrasound Sales at Esaote North America, expressed enthusiasm about this partnership, stating, "We have maintained a robust global relationship with Schiller for many years. Expanding this collaboration to the U.S. market allows us to combine our strengths, ultimately providing clinicians with a more complete set of diagnostic tools."

A Fusion of Expertise

The synergy created by this partnership is poised to revolutionize diagnostic processes in the cardiopulmonary field. Francesco Iacona, CEO of Schiller Americas, highlighted the unique benefits of this alliance, emphasizing how it merges the firms' expertise. He stated, "The combination of Esaote's prowess in ultrasound imaging and our established leadership in cardiopulmonary diagnostics sets a new benchmark for comprehensive diagnostic solutions in cardiology."

This collaboration manifests a shared objective of both Esaote and Schiller: advancing cardiovascular imaging that is not only high-quality but also flexible and tailored to fit the intricate needs of healthcare professionals. The incorporation of Esaote’s ultrasound technology is expected to facilitate enhanced diagnostic accuracy, ultimately leading to improved patient care and outcomes.

Commitment to Innovation

Esaote, headquartered in Genoa, Italy, boasts a robust presence in over 100 countries, focusing on the manufacturing of medical devices, particularly in Ultrasound, Dedicated MRI, and Healthcare IT. The company is recognized globally for its innovative approaches in medical imaging technology.

On the other hand, Schiller Group, based in Baar, Switzerland, is a leading manufacturer of devices designed not only for cardiopulmonary diagnostics but also for patient monitoring solutions and software tailored for the medical sector. Schiller Americas is committed to providing the latest in cardiopulmonary technology across the United States, Canada, and Latin America, which complements the innovative landscape that Esaote represents.

A Shared Vision for the Future

As both companies move forward with this partnership, the implications extend beyond technological integration. It signifies a holistic approach to improving patient experiences in healthcare settings. With clinical tools and technological advancements working in tandem, the future of cardiac diagnostics looks promising.

In essence, this partnership between Esaote and Schiller Americas is not just about expanding sales channels; it represents a united front aimed at setting new standards in cardiology imaging. By harnessing their respective strengths, both companies hope to lead the way in delivering exceptional care to patients and support to healthcare providers across the U.S.

This dynamic collaboration paves the way for a future where advanced imaging technologies are seamlessly integrated into cardiology practices, ultimately enhancing the quality of care provided to patients.